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Objective(s): Neutrophil sequestration in the lung after cardiopulmonary
bypass has been shown to be dependent on the adhesion molecule CD18.
Thus we sought to determine whether endothelial expression of intercellu-
lar adhesion molecule-1 (a ligand for CD18) in pulmonary capillaries
mediates neutrophil adhesion in this setting. Methods: Seven adult mongrel
dogs underwent 90 minutes of hypothermic cardiopulmonary bypass with
60 minutes of cardioplegic arrest. After warming, dogs were reperfused for
up to 9 hours and lung biopsy specimens were obtained. Lung tissue was
examined by Northern and Western blot analysis and by immunohistologic
methods. Three sham-operated dogs served as time-matched controls.
Results: Northern blots demonstrated increased expression of intercellular
adhesion molecule-1 messenger ribonucleic acid within 5 minutes of
cessation of bypass (or approximately 30 minutes after aortic crossclamp
release), which persisted at 9 hours of recovery and was not present in
controls. Western blots showed intercellular adhesion molecule-1 protein
expression before bypass but a measurable increase in intercellular adhe-
sion molecule-1 protein in four of seven dogs in the bypass group by the
ninth hour of recovery. Pulmonary neutrophil accumulation 9 hours after
cardiopulmonary bypass was greater in those dogs with an increased
intercellular adhesion molecule-1 protein expression. Immunoelectron
microscopy demonstrated the pulmonary capillary endothelium capable of
increased intercullular adhesion molecule-1 protein expression at the
9-hour time point. Conclusions: Cardiopulmonary bypass resulted in
intercellular adhesion molecule-1 induction in the canine lung during
recovery. An increased expression of intercellular adhesion molecule-1
protein in the lung was associated with an increased accumulation of
neutrophils in affected animals. Thus intercellular adhesion molecule-1
expression may serve as a mechanism that predisposes the lungs to
inflammatory cell–mediated injury postoperatively. (J Thorac Cardio-
vasc Surg 1998;115:689-99)
Previous studies by ourselves and others havedocumented that neutrophils accumulate in the
pulmonary capillary bed early after the cessation of
cardiopulmonary bypass (CPB).1-5 Furthermore,
this accumulation of neutrophils contributes to pul-
monary dysfunction and depends on the neutrophil
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surface adhesion molecule CD18.3, 5 Neutrophil
margination and emigration at inflammatory sites
depends in part on the cell’s ability to adhere to the
vascular endothelium. Surface adhesion molecules
on both the neutrophil and the endothelial cell
modulate this process. One counter receptor or
ligand for the leukocyte integrins CD11a/CD18 and
CD11b/CD18 found on vascular endothelium is
intercellular adhesion molecule-1 (ICAM-1).6 This
molecule can be upregulated on the endothelial
surface after ischemia-reperfusion or after cytokine
stimulation.7, 8 Thus the lungs may be susceptible to
increased neutrophil accumulation after bypass
caused, in part, by the upregulation of the adhesion
molecule ICAM-1 on pulmonary capillary endothe-
lium.
The purpose of this study was to examine the
regulation of ICAM-1 in the canine lung after CPB
and to determine whether expression of ICAM-1
protein on the pulmonary capillary endothelium
correlated with the sequestration of neutrophils in
the lung postoperatively. Accordingly, lung biopsy
specimens obtained from dogs before and after CPB
were examined by Northern blot analysis for
ICAM-1 mRNA by Western blot analysis for newly
expressed ICAM-1 protein and by immunohisto-
logic examination for neutrophil sequestration and
specific tissue localization of ICAM-1 protein.
Methods
Animal preparation. Healthy adult mixed breed dogs
(16 to 25 kg) were anesthetized with sodium pentobarbital
(30 mg/kg), intubated, and mechanically ventilated with
100% oxygen. After femoral arterial cannulation, ventila-
tory rate and tidal volume were adjusted to establish a
normal pH and carbon dioxide tension as determined by
arterial blood gas. After midline thoracotomy, CPB was
achieved by selective venous cannulation of the inferior
and superior venae cavae with arterial return directed into
the distal aortic arch. The bypass circuit used consisted of
a cardiotomy reservoir and variable prime membrane
oxygenator (Cobe Cardiovascular, Inc., Arvana, Colo.), a
heat exchanger, and a roller pump (Sarns/3M Healthcare,
Ann Arbor, Mich.). The circuit was primed with 40 to 50
ml/1 kg body weight lactated Ringer’s solution. Before
CPB, the circuit was demonstrated to be free of endotoxin
by Limulus amebocyte lysate assay.
Two groups of animals were included in this study. The
first group, designated “CPB,” consisted of seven animals
that underwent CPB with an aortic crossclamp time of 60
minutes and total bypass times of approximately 90 min-
utes. Before cannulation, animals were anticoagulated
with 100 U/kg porcine heparin sodium. After the aorta
was crossclamped, the heart was arrested with prograde
administration of cold potassium cardioplegia given to
effect (Plegisol, Abbott Laboratories, North Chicago, Ill.)
and the animals were cooled to 24° to 28° C. Flow was
maintained during bypass at 60 to 70 ml/kg/min at a
pressure of 40 to 60 mm Hg. After rewarming and
weaning from CPB, animals received protamine sulfate, 1
mg/100 U heparin, delivered for reversal of anticoagula-
tion. Animals were once again ventilated with 100%
oxygen. Tidal volume and ventilator rate were set to
optimize pH and carbon dioxide tension. Animals were
then maintained with the chest open for up to 9 hours
while pulmonary tissue samples were obtained. Technique
was maintained as constant as possible from one animal to
the next.
The second group consisted of three animals designated
“sham bypass” controls. These animals served as controls
in that they received general anesthesia and mechanical
ventilation similar to the animals in group 1. In addition,
they underwent midline thoracotomy and cannula place-
ment, but they were not placed on CPB. Also, these
animals were not subjected to cooling and rewarming or
hemodilution, and there was no reduction of pulmonary
blood flow at any time during the procedure. These
animals, however, were maintained with the chest open
for a similar duration to those animals in group 1. Two
animals received heparin anticoagulation and protamine
reversal as described for group 1 above, whereas one
animal did not. No differences were observed in any of the
measured parameters detailed below for the two sham
animals receiving heparin and protamine and the single
animal that did not. Their results, therefore, were com-
bined.
Approval. The animal studies in this manuscript were
reviewed and approved by the Baylor College of Medicine
Animal Care and Use Committee. All animals received
humane care in compliance with the “Principles of Labo-
ratory Animal Care” formulated by the National Society
for Medical Research and the “Guide for the Care and
Use of Laboratory Animals” prepared by the Institute of
Laboratory Animal Resources and published by the Na-
tional Institutes of Health (NIH publication No. 86-23,
revised 1985).
Northern blot analysis. Lung biopsy material was im-
mediately snap frozen in liquid nitrogen on collection and
ribonucleic acid (RNA) extraction was carried out on the
same day. RNA was isolated from lung biopsy material
using the acid guanidinium phenol chloroform solvent
extraction method.9 Northern analysis of isolated RNA
was subsequently performed with 1% agarose formalde-
hyde denaturing gels and capillary transfer to nylon
membranes using standard procedures.10 Loading of
RNA was monitored using ethidium bromide staining.
Membranes were hybridized in Quikhyb rapid hybridiza-
tion buffer (Stratagene, La Jolla, Calif.) containing ;1 3
106 dpm/ml random monomer 32P-labeled canine
ICAM-1 cDNA probe and 0.15 mg/ml salmon sperm
DNA at 68° C for 2 hours. After washing, filters were
exposed to Hyperfilm-MP (Amersham International Ltd.,
Bucks, UK) as previously described.11-13
Western blot analysis. Lung tissue was snap frozen in
liquid nitrogen and stored at –70° C until use; when
thawed, the tissue was extensively flushed with 50 mmol/L
Tris, 0.2 mmol/L phenylmethylsulfonyl fluoride buffer,
and homogenized with 1⁄4 volume of the same. The
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homogenate was centrifuged for 3 minutes at 1000g at
4° C, the supernatant was collected and the protein con-
centration of the supernatant was determined by the
Biorad Bradford method. Ten micrograms of supernatant
protein was fractionated under reducing conditions (SDS)
on 7.5% polyacrylamide and transferred to an Immo-
bilon-P membrane (Millipore Corporation, Bedford,
Mass.). After blocking for 1 hour (5% milk, 0.1% Tween-
20), primary antibodies (rabbit anti-canine ICAM-1 poly-
clonal antiserum, 1:20,000 [Scios, Inc., Mountain View,
Calif.] and mouse anti-actin, 1:5000 [Amersham]) were
incubated overnight at room temperature. The membrane
was washed in phosphate-buffered saline solution and
incubated 2 hours with secondary antibodies (goat anti-
rabbit and goat anti-mouse) conjugated with horseradish
peroxidase. The membrane was washed, developed in
ECL reagent (Amersham) and exposed to Kodak X-AR
film. Blot intensity was measured using a scanning densi-
tometer (AlphaImager 2000, Alpha Innotech, San Lean-
dro, Calif.). Actin detection was included in the Western
analysis as an internal standard because actin protein
concentration was not expected to change in the lung over
the course of the study. ICAM-1 blot intensity was there-
fore indexed to actin in each lane to control for loading
conditions. Within a single blot, changes in ICAM-1
during reperfusion were then expressed as a percentage of
the pre-CPB ICAM-1 blot intensity.
Neutrophil sequestration. Canine lung tissue was im-
mersion-fixed in 10% buffered zinc-formalin, embedded
in paraffin, and 4 to 5 mm sections were cut using a rotary
microtome. Tissue sections were incubated with SG8H6,
an immunoglobulin G1 murine monoclonal antibody to a
canine neutrophil specific antigen,14 using the Vectastain
mouse kit (Vector Laboratories, Inc., Burlingame, Calif.).
Antibody detection used the peroxidase-based system
with diaminobenzidine (Vector Laboratories) as a sub-
strate. The sections were counterstained with eosin.
Stained tissue sections were analyzed using an image
analysis software program (OPTIMAS, Bioscan Inc.,
Washington, D.C.). Images of lung tissue were captured
using a black and white camera (CCD72, Dage MTI)
connected to a Leitz Diaplan microscope with frame
grabber support with an ALR 486/66 MHz personal
computer. Neutrophils in a given 403 field were distin-
guished by their differential gray-scale intensity compared
with the eosin-counterstained lung tissue. A mean neutro-
phil count was determined from a minimum of 20 ran-
domly chosen fields and was expressed as the number of
cells per cross-sectional area of alveolar air space.
Immunoelectron microscopy. Canine lung was inflated
and fixed with phosphate-buffered saline containing 8%
paraformaldehyde for 4 hours at 4° C. Lung tissue was cut
into small cubes and cryoprotected overnight at 4° C in
phosphate-buffered saline containing a mixture of polyvi-
nylpyrrolidone (PVP, 20%) and sucrose (1.84 mol/L).
Cryoprotected lung tissue was frozen in liquid nitrogen
and then sectioned on a cryoultramicrotome at –85° C.
Ultrathin (80 to 100 nm) cryosections of lung tissue were
immunogold labeled with CL18/1 (anti-canine ICAM-1
Mab)15 followed by secondary antibody conjugated to
colloidal gold (10 nm). Immunogold-labeled cryosections
were viewed on a JEOL 200 CX transmission electron
microscope (JEOL USA, Inc., Peabody, Mass.) and pho-
tographed at 10,0003 magnification. ICAM-1 expression
Fig. 1. Northern blots demonstrating the time course of pulmonary ICAM-1 mRNA expression from two
representative animals. A, In this sham bypass animal, samples time matched to those obtained during a
cardiopulmonary bypass experiment showed a minimal ICAM-1 mRNA expression. B, In this animal
undergoing cardiopulmonary bypass, there was a marked increase in ICAM-1 mRNA expression in the
lung 5 minutes after complete cessation of the bypass procedure (or approximately 30 minutes after the
release of the aortic crossclamp and lung reperfusion). This expression persisted at 3, 6, and 9 hours of
reperfusion. Note the difference in exposure time of the two blots.
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was subsequently quantitated by counting the number of
colloidal gold particles on the cell surface, which was then
expressed as gold particles per mm of capillary wall.
Results
Northern blot analysis. Northern blot analysis
for pulmonary ICAM-1 expression was performed
on tissue samples obtained from all bypass and sham
animals included in the study. To determine the
time course of ICAM-1 expression, samples were
obtained at 5 minutes after the complete cessation
of CPB (or approximately 30 minutes after the
release of the aortic crossclamp with subsequent
myocardial and pulmonary reperfusion), and at 3, 6,
and 9 hours of reperfusion in the bypass animals,
and at matched time points in the sham animals.
Representative Northern blots demonstrating the
time course of ICAM-1 mRNA expression in the
lung are presented in Fig. 1. All animals in the study
had results consistent with those presented in the
figure. Pre-CPB samples had little or no ICAM-1
mRNA present. However, in dogs undergoing CPB
(Fig. 1, B), a marked increase in ICAM-1 mRNA
was seen at the earliest time point sampled after the
bypass procedure. Although not as dramatic, a
sustained increase in ICAM-1 expression at 3, 6, and
9 hours also occurred after bypass. In contrast, sham
bypass animals (Fig. 1, A) had only a weak ICAM-1
mRNA signal present at matched time points “af-
ter” bypass. Furthermore, in the dogs undergoing
CPB the observed increase in ICAM-1 message
present after bypass appeared to be homogeneous
throughout multiple segments of the lung, as dem-
onstrated in Fig. 2.
Western blot analysis. Representative Western
blot analyses from a single animal undergoing CPB
Fig. 2. Representative Northern blot analysis of ICAM-1
expression in a single cardiopulmonary bypass animal and
in a single time-matched sham bypass control at 6 hours of
reperfusion. PRE samples in both animals demonstrated
little or no ICAM-1 mRNA expression. The POST sample
in the sham animal demonstrated a minimal increase in
mRNA expression, whereas the POST samples in the dog
undergoing bypass demonstrated a much greater increase
in ICAM-1 expression. Samples obtained from multiple
regions of the lungs in the bypass dog demonstrated the
increase in ICAM-1 mRNA expression to be a homoge-
neous response. RU, Right upper lobe, RM, right middle
lobe, RL, right lower lobe, LU, left upper lobe.
Fig. 3. Western blots demonstrating the time course of
pulmonary ICAM-1 protein expression in two represen-
tative animals. SHAM, In this time-matched sham bypass
animal, there was constitutive expression of ICAM-1
protein in the lung before the procedure but no increase
in ICAM-1 protein expression relative to the prebypass
amount was detected at any of the later timepoints.
BYPASS, In this animal undergoing cardiopulmonary
bypass, at 3 and 6 hours after the bypass procedure there
was no increase in ICAM-1 expression relative to the
prebypass amount, but at 9 hours after cardiopulmonary
bypass, ICAM-1 protein expression increased appreciably.
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with 9 hours of reperfusion and a time-matched “sham
bypass” control are presented in Fig. 3. All dogs
demonstrated a variable but significant amount of
ICAM-1 protein in the tissue samples obtained after
thoracotomy and before CPB. Against this back-
ground, a detectable increase in ICAM-1 protein
expression was apparent only in the CPB animals. The
collective results of all the study animals are demon-
strated by the plots in Fig. 4. All three sham animals
had no increase in ICAM-1 expression throughout 9
hours of recovery (Fig. 4, A). In four of seven animals
undergoing 9 hours of reperfusion after CPB, how-
ever, there was a threefold or greater increase in
ICAM-1 protein expression at the 9-hour time point
(Fig. 4, B). A comparable increase in ICAM-1 protein
was not seen at 3 and 6 hours after CPB.
Neutrophil sequestration. On the basis of the
observations made in Fig. 4, study animals were
divided into three groups including “sham bypass”
controls (n 5 3), CPB animals with a threefold or
greater increase in ICAM-1 protein expression at 9
hours of recovery (n 5 4), and CPB animals with
little or no increase in ICAM-1 protein expression at
9 hours (n 5 3). Pulmonary neutrophil counts were
determined by a blinded observer for each group
before CPB and at 9 hours of recovery. As shown in
Fig. 5, A, a similar number of neutrophils was
present in the lung in each group before CPB. At 9
hours of reperfusion, however, the group with in-
creased ICAM-1 protein also had a significantly
increased number of neutrophils present. Further-
more, when all animals from each group were
considered collectively, linear regression analysis
demonstrated a positive correlation between the
increase in ICAM-1 expression at 9 hours of recov-
ery and the number of neutrophils present in the
lung at the same time point with r 5 0.75 and p 5
0.01 (Fig. 5, B).
Immunoelectron microscopy. Immunoelectron
microscopy was used to identify the specific tissue
localization of the increased ICAM-1 protein de-
tected by Western blot analysis. Standard immuno-
histologic studies and light microscopy did not allow
for the differentiation of ICAM-1 expression on
alveolar epithelial cells versus capillary endothelial
cells because of their close approximation, necessi-
tating the ultrastructural detail available by electron
microscopy. Antibody recognizing ICAM-1 was rec-
ognized by a secondary antibody conjugated to
colloidal gold that appears as a black bead on the
electron micrograph. As depicted in Fig. 6, A, tissue
sections taken at 9 hours after bypass from a dog
with an increased neutrophil count showed gold
beads present on the lumenal surfaces of both type
I alveolar epithelial cells and capillary endothelial
cells. Similarly treated sections of lung obtained
from the same animal before CPB demonstrated
ICAM-1 immunoreactivity on alveolar epithelial
cells only. On the capillary endothelium, no signifi-
cant amount of immunoreactivity above background
(nonspecific IgG control) was detected. Similarly,
one time-matched sham control and two CPB dogs
with low pulmonary neutrophil counts failed to show
ICAM-1 on the capillary endothelium at the 9-hour
time point. Fig. 6, B , graphically represents the
change in capillary endothelial ICAM-1 expression
in the dog depicted in Fig. 6, A, and suggests
approximately a fourfold increase in gold bead
density over the prebypass value.
Discussion
The results of this study clearly demonstrate the
presence of the adhesion molecule ICAM-1 in the
pulmonary microcirculation after CPB and also sug-
gest that ICAM-1 expression contributes to the
capillary sequestration of neutrophils in the lungs
postoperatively. Our data showed an induction of
the ICAM-1 gene in the lung after CPB, an in-
creased expression of ICAM-1 protein in the lung
that correlated with an increase in pulmonary cap-
illary neutrophil sequestration, and ultrastructural
evidence that pulmonary capillary endothelial cells
express ICAM-1.
To put these results into context, a brief discus-
sion of neutrophil trafficking in the lung is necessary.
Unlike the systemic vascular bed, where the site of
neutrophil margination, sequestration, and emigra-
tion is in the postcapillary venules, neutrophil mar-
gination and sequestration in the lung primarily
takes place in the alveolar capillaries.16, 17 Normally,
the lung contains a large number of marginated
neutrophils (i.e., unactivated cells that are tran-
siently removed from the circulation but are readily
mobilizable to replete the circulating pool) within its
capillary bed. Activated neutrophils sequester
within the same capillary bed, but sequestration
implies an active process and neutrophil retention is
likely to be sustained. Both the neutrophil and the
capillary endothelium may be involved in the se-
questration process. Many of the factors that regu-
late this process, however, remain unknown. One
important mechanism for the initial retention of
activated neutrophils in the pulmonary capillary bed
is a stimulus-induced decrease in their deformabil-
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ity. Intravascular inflammatory mediators, including
complement fragments, can decrease neutrophil de-
formability within 1 minute of binding to the neu-
trophil surface and prevent neutrophils from pas-
sively conforming to the shape of the narrow
capillary lumen.18, 19 This stiffening of the neutro-
phil, however, is transient, even if the stimulus is
sustained.
20
Thus additional mechanisms are neces-
sary to sustain neutrophil sequestration.
Both leukocytes and endothelial cells are capable
of expressing adhesion molecules that influence the
sequestration process. Neutrophils constitutively ex-
press on their surface the adhesion molecule com-
plex CD11/CD18. Three heterodimers, CD11a/
CD18, CD11b/CD18, and CD11c/CD18 are present.
On neutrophil activation by a chemotactic stimulus,
the CD11/CD18 expressed on the neutrophil surface
undergoes a conformational change to an activated
state capable of enhanced recognition of an endo-
thelial ligand, and an increase in surface expression
of CD11b/CD18 from granular stores occurs.6, 17
One ligand for neutrophil CD11/CD18 present on
endothelial cells is a member of the immunoglobulin
supergene family, ICAM-1. Burns and colleagues 21
have demonstrated that, in contrast to venular en-
dothelium in the systemic vascular bed that consti-
tutively expresses ICAM-1, in the mouse, the pul-
monary capillary endothelium has little or no
constitutive ICAM-1 expression. Pulmonary capil-
lary endothelium, however, can produce ICAM-1 in
response to specific stimuli.
Previous studies in animals and in patients have
documented neutrophil activation in response to
CPB.22-27 This activation has included increased
expression of surface CD11b/CD18.24, 26, 27 In our
canine model of CPB we have documented neutro-
phil sequestration, associated with pulmonary injury
and dependent on expression of neutrophil CD18,
within the pulmonary capillary bed 3 hours after
CPB.5 In light of these results and the preceding
discussion, it was logical to examine the canine lung
after CPB for ICAM-1 regulation. In vitro compar-
isons of cultured canine jugular vein endothelial
cells and human umbilical vein endothelial cells in
our laboratory have previously suggested that cyto-
kine induction of and expression kinetics of ICAM-1
Fig. 4. Plots representing the collective data for ICAM-1 protein expression in the lung as determined by
Western blot analysis. Values for ICAM-1 are expressed as a change from the PRE bypass sample as
determined by densitometry. A, Results from three sham bypass controls demonstrate no appreciable
increase in ICAM-1 expression at matched timepoints 3, 6, and 9 hours of recovery. B, Results from
animals undergoing cardiopulmonary bypass demonstrate a threefold or greater increase in ICAM-1
expression in four of seven animals at 9 hours of recovery but no appreciable increase in ICAM-1
expression at earlier timepoints. (NOTE: Samples were not available for testing in every animal at 3 hours
and at 6 hours of recovery.)
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are quite similar in the two species. To our knowl-
edge, however, before this study no attempt to
measure pulmonary endothelial ICAM-1 expression
has been made in the context of CPB in patients or
in animal models.
Our Northern blot data clearly indicated an in-
duction of the ICAM-1 gene in the lung as early
after the cessation of CPB as it was feasible to
measure. This elevation of ICAM-1 mRNA was
sustained throughout the 9-hour course of recovery
after bypass. Western blots of lung tissue homoge-
nates demonstrated a significant amount of ICAM-1
protein expression in the lung before CPB. Ultra-
structural immunohistologic examination suggested
most of this ICAM-1 expression was limited to type
I alveolar epithelium, an observation consistent with
previous studies in the mouse.21 An increase in
ICAM-1 protein expression was not detectable by
Western blot at 3 and 6 hours of reperfusion, but at
9 hours of reperfusion four of seven animals dem-
onstrated ICAM-1 protein expression to be measur-
ably increased. Ultrastructural immunohistologic
studies at this time point confirmed that the pulmo-
nary capillary endothelium was capable of ICAM-1
protein expression after bypass. Furthermore, neu-
trophil localization at 9 hours of recovery was
increased in those dogs with increased ICAM-1
protein expression, lending support to the concept
that this increased ICAM-1 expression on capillary
endothelium was functionally significant.
Although this study documents the induction of
ICAM-1 in the lung after CPB, it also raises other
questions. The stimulus causing induction of pulmo-
nary ICAM-1 is unclear. Also, it is unclear why some
animals responded to bypass with increased
ICAM-1 protein expression and others did not.
Horgan and colleagues 7 have demonstrated that
one stimulus that can increase pulmonary ICAM-1
is ischemia/reperfusion. During bypass, the lung is
handled uniquely in that after crossclamping the
aorta, along with the heart, it is the only organ
excluded from flow through the extracorporeal cir-
cuit (with a minor contribution of blood flow
through the bronchial circulation). Unlike the heart,
however, it does not receive cold cardioplegic solu-
tion. Thus the lung may suffer an ischemic insult,
with subsequent reperfusion at the end of bypass.
Ischemia/reperfusion may have a direct effect on the
Fig. 5. A, Comparison of neutrophil (PMN) localization in the lung before and 9 hours after cardiopul-
monary bypass as determined by immunohistology and computerized image analysis. Number of
neutrophils is expressed as PMN per square millimeter alveolar surface area. On the basis of the 9 hour
results in Fig. 4, animals were separated into three groups: SHAM, sham bypass controls, n 5 3; CPB HIGH
ICAM-1, n 5 4; and CPB LOW ICAM-1, n 5 3. Values are expressed as mean 6 SEM.* p 5 0.03 vs SHAM,
determined by t test. B, Linear regression analysis demonstrating a significant correlation between the
number of neutrophils sequestered in the lung at 9 hours of recovery and the change in ICAM-1 expression
at 9 hours of recovery relative to ICAM-1 expression prebypass.
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pulmonary capillary endothelium, or a second mes-
senger, such as tumor necrosis factor-a, produced
locally in response to ischemia/reperfusion may act
as a stimulus. Alternatively, substances capable of
endothelial activation, released into the blood in
response to blood exposure to the extracorporeal
circuit, may affect the capillary endothelium during
reperfusion. The extent to which any of these regu-
lating mechanisms may be active, however, is pres-
ently unknown.
Our observations also raise other interesting pos-
sibilities. As mentioned above, in our previous stud-
ies in this canine model, pulmonary capillary neu-
trophil sequestration was increased three- to
fourfold 3 hours after bypass. This sequestration was
clearly CD18-dependent, as documented by sys-
temic administration of a blocking anti-CD18 anti-
body.5 Whether ICAM-1 participates in this early
process, however, remains unclear. Western blot
data from the this study failed to show an increase in
ICAM-1 protein at the 3-hour time point, raising the
possibility that neutrophil sequestration at 3 hours
after bypass, although CD18-dependent, could be
independent of ICAM-1 protein expression on the
capillary endothelium. Another CD18-dependent
mechanism could be active at this early time point
Fig. 6. A, Transmission electron micrograph of ICAM-1 protein tissue localization in the peripheral lung
at 9 hours of reperfusion after cardiopulmonary bypass in a dog with increased neutrophil localization.
ICAM-1–specific gold particles were detected on the lumenal surfaces of both the alveolar epithelium
(open arrows) and the capillary endothelium (solid arrows). Similarly treated sections of lung obtained
before CPB in the same animal demonstrated ICAM-1 immunoreactivity on the alveolar epithelium, but
on the capillary endothelium only a trace of immunoreactivity was detected. B, Plot demonstrating the
change in pulmonary capillary endothelial ICAM-1 protein expression in the dog depicted in A. ICAM-1
protein density is expressed as gold beads/mm of capillary wall. Electron micrographs were arranged in
montages for the purpose of counting. PRE values were based on an examination of 330 mm of capillary
wall from 18 separate vessels. POST values were based on examination of 127 mm of capillary wall from five
separate vessels. Values are expressed as the mean 6 SD based on the number of vessels counted. N,
Neutrophil; bar 5 1 mm.
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(e.g., homotypic aggregation or CD18 recognition of
another endothelial ligand). Alternatively, enough
ICAM-1 was expressed on the endothelium at this
time point to support adhesion but was below our
ability to detect its presence against the background
ICAM-1 protein present because of expression on
the alveolar epithelium.
What is clear from this study, however, is that at 9
hours of reperfusion, those dogs with increased
ICAM-1 protein expression had an increased num-
ber of sequestered neutrophils. Animals with lower
ICAM-1 expression had much lower numbers of
neutrophils present. These data suggest, although
do not prove, that the increased expression of
pulmonary ICAM-1 played a role in the sustained or
continued sequestration of neutrophils at later time
points of reperfusion. Alternatively, other adhesion
ligands, co-expressed with ICAM-1 but not mea-
sured in this study could contribute to the seques-
tration process. Nevertheless, the variable response
in ICAM-1 protein expression observed between
individual animals in this study suggests that some,
yet not others, may be predisposed to inflammatory
cell-mediated pulmonary injury later in recovery.
These interesting observations warrant the perfor-
mance of additional studies, not only to more fully
understand the regulation of pulmonary ICAM-1
after CPB but also to determine whether pulmonary
ICAM-1 expression is of pathophysiologic signifi-
cance to the patient undergoing cardiac surgery.
We thank Lloyd H. Michael, PhD, for supervision of the
surgical model and C. Wayne Smith, MD, and Mark L.
Entman, MD, for their critical review of the manuscript.
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Commentary
If sufficiently sensitive techniques are used to assess lung
function, virtually all patients undergoing cardiopulmonary
bypass (CPB) have some post-CPB evidence of pulmonary
malfunction.1 Nevertheless, the number of patients in whom
life-threatening lung failure develops is relatively few; full-
blown adult respiratory distress syndrome occurs in only 1%
to 2% of patients. A clinically relevant pathophysiologic
model of pulmonary dysfunction after CPB should therefore
optimally help to explain both the cellular and molecular
basis responsible for this phenomenon in the majority of
patients and also provide leads to the understanding of the
marked inter-patient variability observed.
Pulmonary injury in the CPB setting appears largely
related to complement activation with resultant formation of
terminal complement component soluble mediators, to cy-
tokine generation, to modulation of small molecule media-
tors such as nitric oxide and prostaglandin/leukotriene inter-
mediates, and to neutrophil sequestration; indeed, all these
events may be mechanistically linked, at least in part, both
here and in other circumstances in which ischemia-reperfu-
sion physiology predominates.2 Although there has been
some debate in the literature regarding the importance of
neutrophils in lung injury, most of the apparent discrepan-
cies in results can be explained by considering the pulmonary
reaction to CPB as a biphasic insult—an initial process
occurring rapidly within the first hour that is most dependent
on soluble mediators and relatively independent of cellular
activation, and a second process (1 to 4 hours later) that
critically involves circulating phagocytes.3 This latter phase
prominently includes activated neutrophil sequestration in
the capillaries and generation of cytotoxic activity by those
granulocytes. It is reasonable to postulate that the adhesive
moieties responsible for neutrophil–endothelial cell adhe-
sion in this pathologic setting would be the same molecules
used by neutrophils during normal physiologic processes and
in other pathologic settings.4 Normal neutrophil-endothe-
lium interaction includes selectin-mediated rolling of granu-
locytes along the blood vessel wall, followed by integrin-
mediated extravasation precesses that are called into play
during an inflammatory response. On the neutrophil side,
quantitative and, equally important, qualitative modulation
of both L-selectin and CD11/CD18 b2 integrin moieties in
response to reperfusion, foreign biomaterial contact, and to
the soluble mediator changes induced by CPB itself have
been postulated to be the critical adhesive alterations re-
sponsible for granulocyte activation/extravasation and con-
sequent lung damage; experimental data lend support to this
concept. The current article by Dreyer and associates ad-
dresses the equally relevant endothelial side of this adhesive
interaction and, in particular, modulation of one of the two
major cellular ligands for myeloid CD11a/CD18 and CD11b/
CD18, that is, intercellular adhesion molecule–1 (ICAM-1).
In a canine model of CPB, the authors find that ICAM-1
messenger ribonucleic acid (mRNA) in the pulmonary cap-
illary vasculature increases immediately after CPB, although
curiously surface expression of protein is not detected in
their assay system until approximately 8 hours after the
detection of increased message. Although this represents a
seemingly long delay for the translation process in the setting
of rapid transcriptional up-regulation, the time course for
ICAM-1 protein appearance is consistent with some other
studies of cytokine-induced alterations in expression. It is
indeed possible, as the authors suggest, that both hypother-
mia (known to delay expression of b2 integrins on neutro-
phils) and local tissue hypoxia are responsible for this long
delay from RNA to protein. The results are also consistent
with prior cardiac studies in man carried out by Kilbridge
and colleagues,5 which examined the heart and skeletal
muscle of pediatric patients undergoing CPB for new expres-
sion of mRNA both for ICAM-1 and also for one of the
major endothelial cell selectins (specifically, E-selectin) be-
fore and after CPB. Those investigators also documented a
rapid up-regulation of message for both molecules during
CPB using a ribonuclease protection assay. Hence it appears
that CPB results in generation of “sticky” blood vessel walls,
as well as hyperactive neutrophils, although the significant
differences in time course for the two phenomena leave open
the question of how these two processes interact, if at all, and
whether the endothelial alterations are a primary event in
CPB or a secondary one.
Two additional questions are raised by these studies.
First, is this vessel wall alteration a uniform finding, or
is there significant subject variability? The current
article found up-regulation of pulmonary endothelial
ICAM-1 to occur in only a subset of canine subjects;
Kilbridge’s group5 described a similar phenomenon in
man. Such results could reflect a host of acquired
differences in underlying physiology. One interesting
alternative is that there could be underlying genetic
differences accounting for the variability. It is known
that there are a number of different polymorphic alleles
for ICAM-1, as well as other important adhesion mol-
ecules in the human population. Moreover, some of
these alleles are reported to be associated with an
increased risk for atherogenesis.6 Of course, although
such observations are intriguing, any idea that genetic
differences in either regulatory or structural sequences
for these genes will ultimately explain and/or predict
patient response to CPB is purely speculative.
Finally, one must raise the question of whether these
observations on the response of the pulmonary vascula-
ture to CPB will have direct clinical therapeutic relevance
some day. Support for this notion comes from experi-
ments in radiation-induced lung injury. It has recently
been shown that mice that have been engineered to lack
the functional gene for ICAM-1 and mice that receive
anti-ICAM-1 blocking antibody fail to develop radiation-
induced pulmonary inflammation.7 Thus it is at least
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reasonable to postulate that ICAM-1 could be a future
target for ameliorating post-CPB lung injury. Only more
basic and clinical research will determine whether an
approach to abrogate damage at the end-organ, as op-
posed to abrogating the effector mediator side of the
equation, will ultimately prove clinically useful in CPB.
Brian R. Smith, MD
Departments of Laboratory Medicine and Internal
Medicine
Yale University School of Medicine
New Haven, CT 06520-8035
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